An Activist’s Guide to Tuberculosis Diagnostic Tools

The guide provides an overview of the different tests and strategies for detecting TB and makes recommendations for how activists and clinicians can contribute to improved TB diagnosis.

Read More →

Advocates maintain pressure on the Ministry of Health to facilitate access to delamanid in Peru

TB advocates reiterate the important role the Ministry of Health must play in facilitating access to delamanid for Peruvians with multidrug-resistant TB.

Read More →

Health groups call on Indian Government to urgently make life-saving TB drug available

Health groups call on the Indian Government to incorporate the life-saving TB drug delamanid into the Revised National TB Control Programme.

Read More →

Public health groups welcome Johns Hopkins University and Medicines Patent Pool agreement for development of promising new TB drug

While deal marks a critical step in the fight against TB, health groups warn that the deal lacks safeguards that would ensure worldwide affordability.

Read More →

Advocates encourage Danaher to continue investments in Cepheid’s TB products

TB advocates encourage Danaher, a holdings company that recently acquired Cepheid, to prioritize the continued development of critical Cepheid products for TB.

Read More →

Advocates call on the Indian Prime Minister to ensure availability of new TB drugs to combat drug-resistant TB

Advocates urge Prime Minister Modi to take immediate action to save a young woman, dying of XDR-TB and to roll out life-saving innovations to tackle the growing burden of drug-resistant TB in India.

Read More →

Advocates encourage prioritization of drug-resistant TB research

TB advocates encourage the Global Antimicrobial Resistance Innovation Fund to prioritize research and development for drug-resistant TB.

Read More →

Advocates call for the Philippines Food and Drug Administration to register delamanid

TB advocates encourage the Philippines Food and Drug Administration to approve delamanid, an important treatment option for people with multidrug-resistant TB.

Read More →

MSF calls on Johnson & Johnson to improve access to bedaquiline

Médecins Sans Frontières (MSF) urges Johnson & Johnson to ensure widespread access to bedaquiline for the treatment of multidrug-resistant TB.

Read More →

Action Plan to address HIV and TB funding withdrawals in middle-income countries

The document is meant to serve as both a call to action and a plan for coordinating communications and activities to stop the attack on people’s lives and human rights in middle-income countries.

Read More →

Page 3 of 79 · Total posts: 10

←First 2 3 4 Last→